An outbreak of nosocomial infections due to Streptococcus pyogenes (Group A Streptococcus; GAS) occurred in a postsurgery oncology unit and concerned more than 60 patients and lasted 20 months despite enhanced infection control and prophylaxis measures. All GAS strains were characterized (emm genotype, toxin gene profile and pulse-field gel electrophoresis subtype). Selected strains were sequenced and phylogenetic relationship established. Capacity to form biofilm and interaction with human pulmonary epithelial cells and macrophages were determined. Twenty-six GAS strains responsible for invasive infections (II) and 57 for non-II or colonization were isolated from patients (n = 66) or healthcare workers (n = 13). Seventy strains shared the same molecular markers and 69 the same PFGE pattern; 56 were sequenced. They all belonged to the emerging emm89 clade 3; all but 1 were clonal. Whole genome sequencing identified 43 genetic profiles with sporadic mutations in regulatory genes and acquired mutations in 2 structural genes. Except for two regulatory gene mutants, all strains tested had the same biofilm formation capacity and displayed similar adherence and invasion of pulmonary epithelial cells and phagocytosis and survival in human macrophages. This large outbreak of GAS infection in a post-surgery oncology unit, a setting that contains highly susceptible patients, arose from a strain of the emergent emm89 clade. No relationship between punctual or acquired mutations, invasive status, and strain phenotypic characteristics was found. Noteworthy, the phenotypic characteristics of this clone account for its emergence and its remarkable capacity to elicit outbreaks.
Introduction
Group A Streptococcus (GAS, Streptococcus pyogenes) is a human pathogen causing a broad range of diseases, noninvasive and invasive diseases as well as autoimmune sequelae, with an estimated 517,000 deaths per year [1] . These can be community acquired or be the consequence of outbreaks in human settings with high proximity such as schools, military barracks, or hospital wards. Residents of the latter are at increased risk of acquiring GAS infections because of underlying medical conditions favorable to streptococcal infections [2] .
GAS strains are extremely diverse and currently the most widely used typing-method for GAS strains relies on the 5′end of the emm gene sequence that encodes the hypervariable amino-terminus region of the M protein, a surface exposed virulence factor [3] . Among more than 200 emm types defined, the most frequently associated with invasive infections in Europe are emm1, emm28 and emm89, with variable distribution worldwide [4, 5] . Epidemiological studies have evidenced the emergence of given genotypes and more precisely of clones as leading cause of disease in Europe or the United States. Such was the case with the emm1 type and the M1T1 clone in the late 1980s ( [6] and references herein) and more recently of the emm89 type exemplified by the emergent clade or clade 3 variant [7, 8] . The emergence of emm89 strains, most probably of the same clone, has been described in multiple geographic locations [9] [10] [11] [12] [13] [14] [15] [16] . Although emm89 strain recovery from outbreaks has been described previously [17] [18] [19] , the newly emerging emm89 clone has not been decisively implicated in major outbreaks.
In 2012 in a follow-up care and rehabilitation post-surgery oncology unit in France, GAS infections were recorded at an unusual level, and although the state-of-the-art prophylaxis measures were taken, this outbreak lasted 20 months. We investigated at the molecular level, the cause of this outbreak by analyzing all isolates be they from invasive or noninvasive diseases or colonization. The strains were genetically characterized, and using biological and date criteria, fifty-six strains were chosen and sequenced. To shed light on possible reasons for this long-lasting outbreak, we investigated whether the GAS strains involved had specific properties in terms of biofilm formation capacity, interactions with human lung epithelial cells or human macrophages.
Materials and methods

Case definition
Invasive disease is defined through the isolation of GAS from normally sterile sites or the isolation of GAS from non-sterile sites (e.g., sputum, wounds) in the presence of either streptococcal toxic shock syndrome or necrotizing fasciitis and non-invasive disease through the isolation of GAS from a non-sterile site and which developed a clinical syndrome consistent with GAS infection. We defined a carrier as a patient or health care worker with GAS cultured from a non-sterile site and no clinical evidence of infection at the time of culture.
Bacterial strains
All GAS isolates collected during the outbreak were characterized by the French national reference center for streptococci (CNR-Strep) (Table S1 ). emm sequence type was determined by sequencing the variable 5′end of the emm gene and comparing sequences with database of the Center for Disease Control and Prevention (http://www.cdc.gov/ ncdid od/biote ch/strep /doc.htm) [3] . All strains were tested by a multiplex PCR method for the presence of genes encoding the toxins or superantigens SpeA, SpeB, SpeC, Ssa and SmeZ [4] . A prior cluster analysis was carried out by pulsed-field gel electrophoresis (PFGE) with SmaI restriction enzyme and interpreted according to Tenover criteria [20] . Other GAS strains collected by the CNR and similarly characterized were used as controls (Table S2) . Antibiotic resistance profiles were determined according to the European Committee on Antimicrobial Susceptibility Testing guidelines (http://www.eucas t.org).
Bacterial growth conditions
GAS isolates were grown at 37 °C without agitation in Todd-Hewitt broth supplemented with 0.5% yeast extract (THY) or in brain heart infusion (BHI) (Difco). Bacteria were collected in mid-log phase, washed once with sterile phosphate-buffered saline (PBS), and diluted to the required inoculum; the number of viable bacteria was determined by counting the colony forming units (CFUs) after plating dilutions on THY agar.
GAS strain sequencing
Chromosomal DNA was extracted using the MasterPure™ Gram-positive DNA purification kit (Tebu-Bio) and sequenced using the Illumina technology, with read length of 100 nt and a more than 100 fold-coverage. Libraries were constructed using the Illumina TrueSeq kit following the manufacturer's instructions. Illumina short reads were assembled using the Velvet software [21] . Strain 20120499 considered as the outbreak index case was used as a reference for SNPs calling. Contigs of strains 20120499 were ordered by aligning them to the complete genome sequence of strain MGAS315 (emm1, accession number NC_004070.1, no emm89 complete sequence being available at the time of this analysis) using the Mauve software [22] . Each strain was analyzed for SNPs, small indels, and deletions compared to strain 20120499 using the BRESEQ software (pmid 24838886), which allowed the identification of errors in the Velvet assembly. Sequence specific to each strain was analyzed by assembling unmapped reads with Velvet. Accession numbers pending.
Reconstruction of large insertion from fastq files
A Perl software named iSeGWalker was newly developed to accomplish a de novo genome reconstruction from the reads file in fastq format [23] . The search step is an exact-matching reads selection using a regular expression (seed) and a simple Perl script, reading each sequence one by one. Once all matching reads of the index case genome (20120456) had been selected, a consensus sequence was determined; then, a new seed, composed by the 30 last consecutive nucleotides, was obtained and a new search was performed.
Phylogeny analysis
Phylogenetic analyses were performed after alignment of all strains against the new reconstructed sequence as reference. The evolutionary history was inferred using the Neighbor-Joining method [24] . The evolutionary distances were computed using the Maximum Composite Likelihood method [25] and were in the units of the number of base substitutions per site. The rate variation among sites was modeled with a gamma distribution (shape parameter = 1). The differences in the composition bias among sequences were considered in evolutionary comparisons [26] . All positions containing gaps and missing data were removed for each sequence pair. Evolutionary analyses were conducted in MEGA7 [27] .
PCR amplification
The DNA sequence surrounding the has operon was amplified using the oligonucleotides Has-M89_F CTG TGC CAC TAA GAC TCT TT and Has-M89_R CGG ACA GGT GCA GTTGG-TTT using the GoTaq ® Green Master Mix with an elongation time of 4 min.
Biofilm formation assay
Overnight cultures grown in BHI, for optimal abiotic biofilm formation as described in Koller et al. [28] , were diluted to an optical density at 600 nm (OD 600 ) of 0.06 and 180 µL were distributed in quadruplet in 96-well plates. After 24 h static growth at 37 °C, one plate was used to record the OD 595 after resuspension, while the other one was treated with crystal violet as described by Koller et al. [28] except that the aqueous 1% SDS solution was replaced by a 80/20 ethanol/acetone solution. Biofilm formation capacity was defined as the ratio of the OD 595 elicited by crystal violet and the OD 595 due to growth on the control plate. The experiment was carried out at least in triplicate.
Growth kinetics
Overnight cultures grown in THY were diluted 1:100 in fresh THY and 150 µL were distributed in quadruplet in 96-well plates. The plates were incubated at 37 °C in a Thermo Scientific Multiskan™ GO microplate spectrophotometer. OD 600 was measured every 10 min after agitation.
Human lung epithelial cell culture and adhesion and invasion assays A549 cells were grown in DMEM-Glutamax 10% Fetal Calf Serum (FCS) in 24-well plates during 2 days, washed with PBS, and infected with mid-logarithmic GAS resuspended in RPMI cell-culture medium at a multiplicity of infection (MOI) of one bacterium/cell. For adhesion assays, the plates were centrifuged 5 min at 1000 rpm and incubated 1 h at 4 °C; the non-adherent extracellular bacteria were then eliminated removing the culture medium and washing three times with sterile PBS. For internalization assays, the plates were further incubated 45 min at 37 °C, 5% CO 2 , and the adherent extracellular bacteria were subsequently killed by incubation with fresh medium containing 50 U/ mL penicillin/ and 50 µg/mL streptomycin for 30 min. After washing with PBS A549 cells were lysed with 1 mL cold sterile distilled water and serial dilutions were plated on THY plates and the number of CFUs was determined after 24-48 h growth at 37 °C. For all experiments, four or five independent assays in duplicate were carried out for each bacterial isolate.
Human macrophage culture and infection assays
To differentiate the THP-1 into macrophages, 2 × 10 5 to 4 × 10 5 cells were inoculated in RPMI GluMax supplemented with 10% FCS and 200 nM PMA (Phorbol 12-myristate 13-acetate) (Sigma, P1585). After 3 days at 37 °C, 5% CO 2 , the medium was replaced with RPMI GluMax supplemented with 10% FCS and the incubation extended for 5 days. Cells were then infected with mid-logarithmic GAS resuspended in RPMI medium at a MOI of 1. The phagocytosis and survival assays were carried out as previously described [29] .
Statistical analyses
Significance of differences in biofilm formation capacities was assessed by Student's t test. That of cellular adhesion, invasion, phagocytosis and survival were assessed by Repeated measures Anova and Turkey's multiple comparison test, GraphPad software.
Results
Outbreak description
From 16th April through 7th May 2012, 4 cases of invasive GAS infections were recorded in a 100-bed post-surgery oncology unit (Fig. 1 ). To limit secondary cases, epidemiological investigations were started among the patients and healthcare workers to determine their status against GAS. Although appropriate hygiene measures were taken this outbreak lasted until 23rd December 2013 concerned 66 cases and ended after mass chemoprophylaxis by azithromycin 500 mg per os once daily for 3 days and enhanced infection control such as mask wear, hand hygiene and the implementation of appropriate disinfection measures for tracheostomy cannula.
Almost all the patients had surgery for an oral cancer and were in second line of treatment with radiotherapy. Men accounted for 83% (55/66) of the patients and the mean age were 61 year old (range 24-87) and 67.5 year old (52-83) for men and women, respectively (Table S1 and data not shown).
During the outbreak, 26 cases of GAS invasive infections were identified, 13 bacteremia, 11 pneumonias, and 2 necrotizing fasciitis, among which 5 (19.2%) died. During the epidemiological surveillance, 57 non-invasive GAS strains were isolated; 44 from patients and 13 from healthcare workers with direct patient-care responsibilities (Table S1) .
GAS patients' strains were isolated from blood cultures (n = 13), oropharynx (n = 9), wounds (n = 13), gastrostomy sites (n = 8), tracheostomy cannula (n = 8), respiratory specimen (n = 18), and lymphadenectomy (n = 1). All 13 GASpositive cultures from healthcare workers were from the oropharynx. A total of 83 GAS strains were thus isolated between April 2012 and December 2013 including 26 invasive, 38 non-invasive, and 19 from colonization. An invasive respiratory device was present in 13/26 (50%) patients with an invasive infection and in only 12/44 (27%) patients colonized or without an invasive infection, p = 0.049.
Genetic characterization of the GAS strains
All strains were genotyped (Table S1 ). All invasive but 1 (25/26) and 51 out of 57 non-invasive or colonization strains shared the same emm89 genotype. 69/76 (91%) emm89 GAS strains, be they invasive, non-invasive or colonization strains, were indistinguishable by PFGE displaying an 89-A4 pattern according to our nomenclature (Table S1 and data not shown). Patterns of the seven emm89 remaining strains showed a maximum of four differences. All 76 emm89 strains displayed a low-level resistance to aminoglycosides (kanamycin and gentamicin) and were susceptible to β-lactams, vancomycin, macrolides, and tetracycline except two non-89-A4 strains that were resistant to tetracycline due to the presence of tet(M) determinant located on Tn916 related conjugative transposon.
Thus, whereas non-89-A4 PFGE and non-emm89 strains were occasionally isolated, 69/83 GAS strains isolated throughout the considered period shared the same emm89 genotype 89-A4 PFGE pattern. This argued for an outbreak origin of these strains; the other strains were considered outside the outbreak. To further analyze these emm89 89-A4 strains, a total of 56 were randomly chosen for sequencing among a subcollection selected according to date and clinical criteria as follows: a balanced distribution, 22/26 and 34/50 isolated in 2012 and 2013, respectively, including the first, index case in 2012, and last of each year, and 9 and 11 invasive infections from 2012 to 2013, respectively. For sake Table S2 ).
Sequence analysis and phylogeny of the GAS outbreak isolates
The alignment of three fastq files, including that of the index case strain (20120499), to H293 emm89 genomic sequence (NC_002737.2), and the use of the Tablet software [30] , led to the identification of 5 areas of possible chromosomal rearrangement sites based on a relative increase in the diversity of these loci. We then reconstructed the new reference genome (see "Materials and methods") (1,747,907 base pairs) and realigned all the fastq files on it. The genomes are 99% identical on a 99% coverage to that of MGAS27061 (accession number NZ_CP013840.1), indicating that these emm89 clinical isolates belong to the new emm89 clade 3, lacking the has operon and harboring the same mutation in the slo-nga promoter region [13, 31] . To get insight into the emergence of this new clade in France we sought, in a collection of emm89 French strains, when the has operon loss could have occurred. The DNA fragment encompassing the has operon was amplified from 15 unrelated strains received by the CNR-Strep during the last 15 years (data not shown). In three of these strains, including one from 2003, the has operon was absent, suggesting the presence of the new clade in France already at that time.
For phylogenetic analyses, we used the whole genome alignment of 61 strains: we combined genomic data obtained from 56 isolates of the 2012-2013 outbreak, one emm89 control strain independent of this outbreak (20120256), three strains isolated in 2014 at a time-related distance from the outbreak, and the reference MGAS27061 an emm89 clade 3 strain [7, 8] (Fig. 2; Table S2 ). This tree (Fig. 2) clearly shows the monophyletic character of the 2012/2013 outbreak, well separated from the isolates collected at the same site but in time away from the outbreak (2014 strains). The control strain 20120456 is phylogenetically more distant to the index case strain (42 SNPs compared to the 20120499 index strain) than all other strains. Furthermore, the fact that the reference strain MGAS26761 is positioned between the branches 2012/2013 and 2014, reinforces the independence of the two events, and strongly suggests the extinction of the outbreak episode of 2012/2013 (Fig. 2) .
The tree covering the 55 outbreak strains ( In addition, they have lost the phage harboring speC, and these two strains, nevertheless, belong to the outbreak, loss of a phage being compatible with a convergence event.
The strain 20130948 appears to have a quite peculiar evolutionary history and lies apart from all subclones. Despite these exceptions, this topography is highly compatible with The optimal tree with the sum of branch length = 1.78211648 is shown. Only bootstrap greater than 50% are shown. The tree is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. The analysis involved 66 nucleotide sequences. All positions containing gaps and missing data were eliminated including the region of the 25 kb insertion. There were a total of 206 positions (informative SNP) in the final dataset. 20120456 C in bold red case corresponds to the control strain isolated independently of the outbreak and the strain of the index case is written in black bold case 1 3 an epidemic signature: most strains deriving from a unique colonization event occurring in 2012. The emm89 outbreak subclone was termed emm89-F.
Forty-three genetic profiles were defined (Table S3) . At the gene level, four mutations stabilized over the outbreak period; two occurred in intergenic regions and the two others in genes involved in bacterial metabolism, the oxaloacetate decarboxylase beta chain (ODC), found in 36 strains from 8th September 2012 onward, and the shikimate 5-dehydrogenase I alpha (S5D), found in 33 strains from 25th January 2013 onward. Ten non-stabilized mutations were also found in the gene encoding the serum opacity factor (SOF) among 29 strains. Six non-fixed mutations were also found among eight strains in the gene encoding the CovS regulatory protein. No mutation or group of mutations could be related to the strain invasive status.
Phenotypic characterization of the emm89-F strains
Isolates of the emm89-F clone were characterized for phenotypes relevant to the clinical settings of this outbreak, i.e., growth capacities, abiotic biofilm formation, interactions with lung epithelial cells and macrophages. Strains were chosen to cover all the branches of the genetic tree and to, altogether, harbor all mutation profiles (Fig. 3, Table S1 ).
Biofilm formation
As mentioned, a significant correlation between the occurrence of invasive GAS infections and the presence of a medical respiratory device was observed among infected patients. (Table S1 ). The recognition that biofilm formation by GAS is involved in persistence (for review [32] ) and that biofilm formation varies among strains within emm genotypes [33] prompted us to assay the capacity of these clinical isolates to form biofilm on abiotic surface (Fig. 4) . All strains were able to form biofilms and most of them in similar amounts; no difference was observed between strains sampled from tracheostomy cannula and from other sites. The stronger biofilm producers are mutated in either the global positive regulator gene mga, yielding values slightly above those of the other strains, or, and more impressively, in covS, the sensor of the CovRS two-component system known to negatively regulate the expression of multiple virulence genes [34] .
We also assessed whether GAS biofilm formation capacities increased during the outbreak. To that aim, we calculated a trend line, after removing the strains mutated in regulatory genes (Fig. S1 ). It slightly raises (y = 0.0362 x + 8.8), but displays no great change in biofilm formation throughout the outbreak.
To assess whether the outbreak isolates were weak or robust biofilm formers, their capacity to form biofilms was compared to that of other unrelated clinical isolates (Fig. 4 , Table S2 ). Biofilm formation being dependent on the CovRS regulatory system, we included only covR covS wild-type isolates from other studies and calculated the mean value for the outbreak isolates excluding all regulatory mutants [35] . The clinical isolates collected during the outbreak formed substantial more biofilms compared to isolates from other emm types, (p = 0.001). In contrast, no difference was observed when comparison was established with other emm89 isolates, also belonging to the emergent clade 3 [7, 8] , (data not shown) indicating that this may be a specific trait to the emerging emm89 clones.
In conclusion, these results show that emm89 outbreak isolates are more robust biofilm formers than non-emm89 isolates; this property could account and contribute for the current emergence and spread of this clone.
Adhesion and invasion into lung epithelial cells
The pathologies observed during the outbreak such as respiratory infections prompted us to analyze the adhesion and invasion of selected clinical isolates into human A549 lung epithelial cells. Four strains were selected, in addition to the index case (IC; 120499), using different criteria to ensure a representative sampling: dispersion throughout the genetic tree and the presence of different mutations, SOF (120811), ODC (120747), S5D (130922), and the regulator CovS (120619) (Fig. 3 and Fig. S1 and Table S1 ). We first assessed that these strains displayed no growth difference in laboratory conditions (data not shown).
Adhesion capacities of these strains were determined and compared to that of an unrelated emm89 strain previously studied [29] . No significant difference in the adhesion capacity of these strains was observed (Table 1) . In contrast, a difference was noted when invasion was compared: the invasion of the covS-mutant isolate was lower than that of all the other strains and was significantly lower than that of the emm89 control strain (Table 1 ). This suggests that these clinical isolates possessed no specific properties in their interaction with pulmonary cells compared to other unrelated GAS emm89 clinical isolates and did not acquire any, through their mutations detected.
Phagocytosis and survival within macrophages
Macrophages are critical host defense cells. We have previously shown that emm89 isolates were more phagocytozed Fig. 4 Outbreak emm89-F isolates form substantial biofilms compared to other non-emm89 GAS strains. Comparison of biofilm formation of isolates from the epidemic clone and of strains from other emm types (Table S2) . For each strain, the mean value of its biofilmforming capacity is indicated. It was obtained by measuring the ratio between the crystal violet elicited OD 595 Results are expressed as the percentages of, for the adhesion, bacterial CFUs recovered after three PBS washing relative to the initial inoculum and, for the invasion, bacterial CFUs recovered after 30 min antibiotic treatment relative to the adherent CFUs. The results represent the mean ± SD of three and five independent experiments, respectively, carried out in triplicate for each isolate, with significance levels indicated between a given strain and the covS-mutant strain types (**p ≤ 0.01) by murine macrophages than non-emm89 strains, that they were differentially phagocytozed depending on their invasive status and that there was a variability within the invasive and non-invasive strains [29] . Consequently, we analyzed the behavior of the outbreak clinical isolates towards uptake and survival in the physiologically relevant THP-1 human macrophages and compared it to that of the emm89 control strain (Fig. 5) . Except for the covS-mutant strain, which seemed less phagocytozed than all other strains and was significantly less phagocytozed than the SOF and S5D strains, all outbreak isolates and the control strain were similarly phagocytozed by THP1 macrophages (Fig. 5a ).
We then tested the survival of these isolates in THP-1 (Fig. 5b) . Only the covS-mutant strain survived, at T2, less than other strains, and significantly less than the index isolate.
This indicates that the outbreak strains and the emm89 control isolate behaved similarly towards the host defense elicited by the human macrophages.
Discussion
This is, to our knowledge, one of the largest outbreaks of GAS infection in a single health care facility among highly vulnerable patients with oral cancer. Here we describe a remarkably long outbreak linked to the persistence and spread of a clone in both patients and healthcare workers. Almost all isolates from patients with GAS infection and those from healthcare personnel were subtype emm89, suggesting that one GAS strain was circulating throughout the healthcare facility. However, we could not determine whether a patient or an infected colonized healthcare worker initiated the outbreak, since investigations began 3 weeks after notification to the authorities of the four cases of invasive infections. In France, emm89 is now among the top three leading emm types, accounting for 19% of all invasive infections in 2017 and the first one (23%) for GAS clustered cases since 2011 (https ://cnr-strep .fr/index .php/bilan s-dacti vite/rappo rts-dacti vite).
Using whole-genome sequencing we demonstrated that this clone belongs to the emerging emm89 clade 3 [7, 8, 14] . Interestingly, most but not all isolates could be phylogenetically grouped on the basis of their sampling year (Fig. 2) . The exceptions suggest that some clones reappeared after a few months during which they were asymptomatically carried. Several data report that this emm89 emerged in many countries in a closely similar time frame during the first decade of the 2000s, accompanied by a swift from clade 1 to clade 2 and subsequent emergence of clade 3 [12] .
The extent of this outbreak and the case-fatality rate of 19% among patients with invasive disease prompted us to shed light on the advantages brought by this specific clone; we studied phenotypic traits such as biofilm formation and interaction with human pulmonary cells or macrophages. The similar high level of biofilm formation displayed by the outbreak and other emm89 clones compared to other emm-type strains could be a consequence of all strains belonging to the emerging emm89 clade. Indeed, emm89 strains were not described as high biofilm producer by Koller et al. [28] , and this could be linked to their strain panel, sampled between 2001 and 2006, that is before the full emergence of this clone [7, 28] . Here, we show that the emm89-F clone, which is uncapsulated, is a robust biofilm former confirming that capsule is dispensable for abiotic biofilm formation [35, 36] . The emm89-F mga mutants, Mga being a global transcriptional activator including of the M and M-like encoding genes, yielded slightly higher biofilm production than the wild-type emm89-F isolates. M and M-like proteins most often contribute to biofilm (Table S2 , [29] ) as described in "Materials and methods" and results are expressed as the percentages of a bacterial CFUs recovered after 30 min antibiotic treatment relative to the initial inoculum and b percentage of phagocytozed bacteria that survived. The results represent the mean ± SD of five independent experiments carried out in triplicate for each isolate, with significance levels indicated between a given strain and the covS-mutant strain types (*p ≤ 0.05; **p ≤ 0.01) formation, which is nevertheless emm-type dependent [35] [36] [37] ; a weaker M and M-like protein production in an emm89 background may have, as in the emm2 background, little influence on biofilm formation [37] . Furthermore, a variation in the abundance of Mga-controlled products, other than the M and M-like proteins, could account for the biofilm increase. CovRS is a two-component system that controls, mainly repressing, the expression of 15% of the GAS genome. Several covS-mutant strains produce less, and others more biofilm than their wild-type counterparts, suggesting that the consequences of mutations in covS on biofilm formation are strain-dependent [35, 38] . The emm89-F covS-mutant isolates were particularly robust biofilm formers supporting the strain-dependent contribution of CovS to biofilm formation and demonstrating that CovRS-controlled products other than the capsule are involved in biofilm formation.
Several reports suggested that acapsular emm89 cladeassociated GAS strains may have acquired potential for long-term colonization [7, 13] . Moreover, the increased expression of SLO and NADase by this clade could enhance internalization and intracellular bacterial survival in epithelial cells, theoretically providing protection from natural antimicrobial peptides and antibiotic treatment. Adhesion and invasion experiments on human epithelial lung cells performed on a representative sampling did not reveal major difference among strains except for the covS strain for which, if adhesion was similar to other strains, its capacity to invade cells was affected. Furthermore, there was a tendency for covS strain to be less phagocytozed and to survive less than the others in the macrophage. Altogether, this meant a disadvantage for this strain for which epithelial cells and macrophages would not act as a reservoir and promote a carrier state. This result is consistent with the report that covS strains are badly transmitted [39] , thus accounting for sporadic apparition of covS mutations during this outbreak.
In this outbreak, the majority of the patients had undergone surgery associated with radiotherapy for oral cancer and belongs to a disadvantaged and highly vulnerable population. These features could explain the very high rate of transmission in fragile patients, where promiscuity was highly problematic.
In conclusion, this report adds France to the growing list of European countries and North America where, by whole genome sequencing, emm89 clade 3 strains have been demonstrated to an emergent clone eliciting GAS infections. It strengthens the fact that the spreading of this clone is worldwide and emphasizes the importance of epidemiological monitoring by reference centers and health authorities. It confirms the relevance, power and robustness of the whole genome sequencing approach for epidemiological analysis of major outbreaks and its routine use for surveillance.
